Drug-Resistant Malaria In Asia Complicating Treatment, Threatening Spread To Sub-Saharan Africa

VOA News: Southeast Asia’s Most Effective Anti-Malaria Drug Is Becoming Ineffective
“Scientists warn the most effective drug used to treat malaria is becoming ineffective in parts of Southeast Asia — and unless rapid action is taken, it could lead to a global health emergency. Writing in The Lancet journal, researchers from Thailand’s Mahidol University and Britain’s Oxford University say parasites that carry malaria are developing resistance to a key drug combination across multiple regions of Cambodia, Laos, Thailand, and Vietnam…” (Ridgwell, 7/29).

Washington Post: A drug-resistant strain of malaria is making the disease ‘almost untreatable’ in southeast Asia
“…A major concern is that the strains will spread to sub-Saharan Africa, where malaria is most common and logistically hard to treat. … Ultimately, scientists say, the only way to completely eradicate these resistant strains is to eradicate the disease itself in the region. Such efforts have taken place around the world since 1955, when the World Health Organization created the Malaria Eradication Program. Since then, dozens of countries have been declared as malaria free, but only two of them, the Maldives and Sri Lanka, are in southeast Asia…” (Mellen, 7/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.